# BioMarin Pharmaceutical, Inc. (BMRN)

BridgeBio's oral infigratinib shows positive Phase [--] results, potentially challenging BioMarin's franchise. Analysts are closely watching the competitive landscape and regulatory outcomes.

### About BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. is a biotechnology company focused on developing and commercializing innovative therapies for rare diseases.  
BioMarin Pharmaceutical, Inc. uses the ticker $BMRN for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- BioMarin Pharmaceutical, Inc. (BMRN) trading volume is up 137.24% from the previous week.
- BioMarin Pharmaceutical, Inc. (BMRN) social dominance is up 581.58% from the previous week.
- BioMarin Pharmaceutical, Inc. (BMRN) Galaxy Score™ is up 19.15% from the previous week.
- BioMarin Pharmaceutical, Inc. (BMRN) creators is up 12.82% from the previous week.
- BioMarin Pharmaceutical, Inc. (BMRN) mentions is up 12.36% from the previous week.
- BioMarin Pharmaceutical, Inc. (BMRN) posts created is up 212.9% from the previous week.

### Price: $59.90
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$bmrn/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$bmrn/time-series/close.tsv)  
The stock is trading near its 1-year low, influenced by broader market downturn and acquisition cost concerns. However, positive sentiment from technical analysis and initiation of coverage by Barclays with an Overweight rating may provide some support, alongside a notable increase in social engagements.  

24-Hour: -0.12%
7-Day: 2.99%
30-Day: 9.67%

1-Year High: $72.80 on 2025-03-27  
1-Year Low: $51.50 on 2025-11-07  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$bmrn/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$bmrn/time-series/alt_rank.tsv)  
BioMarin Pharmaceutical, Inc. (BMRN) is currently AltRank #692 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] [----]  
[--] Month: [---] [----]  
[--] Months: [---] [----]  
[--] Year: [---] +317  
1-Year High: [-----] on 2026-01-26  
1-Year Low: [--] on 2025-02-20  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$bmrn/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$bmrn/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +9  
[--] Month: [--] +1  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-12-19  
1-Year Low: [--] on 2025-06-18  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$bmrn/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$bmrn/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] -2.30%  
[--] Month: [-------] -43%  
[--] Months: [---------] -20%  
[--] Year: [---------] +110%  
1-Year High: [-------] on 2025-02-19  
1-Year Low: [---] on 2025-03-23  

Engagements by network (24h):
News: [--]
YouTube: [---]
X: [------]
Reddit: [---]
TikTok: [---]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$bmrn/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$bmrn/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] +12%  
[--] Month: [---] -25%  
[--] Months: [-----] -1.70%  
[--] Year: [-----] +40%  
1-Year High: [---] on 2025-06-17  
1-Year Low: [--] on 2025-12-15  

Mentions by network (24h):
News: [--]
YouTube: [--]
X: [---]
Reddit: [--]
TikTok: [--]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$bmrn/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$bmrn/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning BioMarin Pharmaceutical, Inc. (BMRN) in the last [--] hours which is down 18% from [---] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +13%  
[--] Month: [---] -23%  
[--] Months: [-----] -21%  
[--] Year: [-----] +81%  
1-Year High: [---] on 2025-06-30  
1-Year Low: [--] on 2025-12-07  

The most influential creators that mention BioMarin Pharmaceutical, Inc. in the last [--] hours

| Creator                                                 | Rank | Followers  | Posts | Engagements |
| -------                                                 | ---- | ---------  | ----- | ----------- |
| [@semodough](/creator/twitter/semodough)                | [--]    | [------]     | [--]    | [-----]       |
| [@upediashorts](/creator/youtube/upediashorts)          | [--]    | [----------] | [--]     | [---]         |
| [@DwightS2025](/creator/twitter/DwightS2025)            | [--]    | [---]        | [--]     | [---]         |
| [@ParadiseTraderr](/creator/twitter/ParadiseTraderr)    | [--]    | [---]        | [--]     | [---]         |
| [@BiotechAnalysst](/creator/twitter/BiotechAnalysst)    | [--]    | [-----]      | [--]     | [---]         |
| [@SMALLCAPSAXIS](/creator/twitter/SMALLCAPSAXIS)        | [--]    | [---]        | [--]     | [---]         |
| [@bpra93](/creator/reddit/bpra93)                       | [--]    | [------]     | [--]     | [---]         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)              | [--]    | [--]         | [--]     | [---]         |
| [@AsAboveSoBelow322](/creator/reddit/AsAboveSoBelow322) | [--]    |            | [--]     | [--]          |
| [@BentheFidler](/creator/twitter/BentheFidler)          | [--]   | [-----]      | [--]     | [--]          |

[View More](/list/creators/$bmrn/100)
  
  
### Sentiment: 58%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$bmrn/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$bmrn/time-series/sentiment.tsv)  
Current Value: 58%  
Daily Average: 70%  
[--] Week: 100% no change  
[--] Month: 65% -6%  
[--] Months: 65% -15%  
[--] Year: 65% +8%  
1-Year High: 98% on 2025-06-27  
1-Year Low: 10% on 2025-12-13  

Most Supportive Themes:
- FDA Approvals and Partnerships: (45%) Positive sentiment regarding potential FDA approvals and strategic partnerships.
- Technical Analysis and Momentum: (25%) Discussions focus on technical analysis and accelerating intraday momentum.
- Financial Performance and Growth: (15%) Mentions of financial updates and revenue growth.
  
Most Critical Themes:
- 52-Week Lows and Market Concerns: (10%) Concerns about hitting 52-week lows and broader market impacts.
- Acquisition Impact on Earnings: (5%) Concerns about the acquisition of Inozyme Pharma negatively impacting EPS.
  
  
  
### Social Dominance: 0.025%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$bmrn/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$bmrn/time-series/social_dominance.tsv)  
Current Value: 0.025%  
Daily Average: 0.021%  
[--] Week: 0.026% +0.022%  
[--] Month: 0.026% +0.0046%  
[--] Months: 0.026% +0.013%  
[--] Year: 0.026% -0.0051%  
1-Year High: 0.072% on 2025-02-20  
1-Year Low: 0.0037% on 2025-12-15  
  
  
### Market Dominance: 0.013%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$bmrn/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$bmrn/time-series/market_dominance.tsv)  
Current Value: 0.013%  
Daily Average: 0%  
1-Year High: 0.027% on 2025-03-12  
1-Year Low: 0.012% on 2025-10-29  
  
  
### Market Cap: $11,501,885,775
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$bmrn/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$bmrn/time-series/market_cap.tsv)  
Current Value: $11,501,885,775  
Daily Average: $11,229,764,856  
[--] Week: $11,501,885,775 +3%  
[--] Month: $11,501,885,775 +8.70%  
[--] Months: $11,501,885,775 +4.30%  
[--] Year: $11,501,885,775 -7%  
1-Year High: $13,894,292,697 on 2025-03-27  
1-Year Low: $9,886,204,142 on 2025-11-07  

### Top BioMarin Pharmaceutical, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Why BlackRock Is Buying BitMine (BMNR) While Retail Investors Panic - BMNR Stock analysis In todays video we take a detailed and balanced look at BMNR stock and the business behind BitMine Immersion Technologies. While some retail investors have mixed opinions recent institutional activity suggests growing interest from larger funds. We analyze the company using price action fundamentals trading volume and overall market sentiment to better understand what may be happening behind the scenes. Inside this video we cover: BMNR stock price movement and volatility Earnings P/E ratio and dividend"  
[YouTube Link](https://youtube.com/watch?v=p4ITEjpFweY) [@bigbstcok](/creator/youtube/bigbstcok) 2026-02-13T21:48Z [----] followers, [---] engagements


"MARKET WAR: Oral vs. Injectable. BridgeBio ( $BBIO ) just fired a shot across BioMarin's ( $BMRN ) bow. The Tale of the Tape: 🧵"  
[X Link](https://x.com/biomednexus/status/2022381733736493502) [@biomednexus](/creator/x/biomednexus) 2026-02-13T18:45Z [--] followers, [---] engagements


"Discord: Top Traders. $SMMT $ZGNX $IONS $PASG $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS $BMRN $ALEC $ALLO $SUPN $TRVI $BIIB $ARVN $ZURA $NVAX $JAZZ $IDYA $INCY $EXEL $CMRX $ALKS $ABCL $DAWN $ICPT http://discord.gg/3KN5mquQMv 🛑 Stop Scrolling. $PROP SMALL-CAP OIL IS HEATING UP Prairie Operating Co. is building something BIG in the DJ Basin 💥 Explosive revenue EBITDA & production growth 💥 Oil-weighted assets = stronger margins in a rising crude environment 💥 Strategic acquisitions adding https://t.co/nFWsHPltVX http://discord.gg/3KN5mquQMv 🛑 Stop Scrolling."  
[X Link](https://x.com/stocket_rocket/status/2022354854602248547) [@stocket_rocket](/creator/x/stocket_rocket) 2026-02-13T16:59Z [--] followers, [---] engagements


"$BMRN as a long time bear even I think these guys can win/maintain share vs $BBIO given safety overhang and parent choice. Both will cede max share to $ASND but Id say $BMRN will still dunk on $BBIO and has a free call option for when FDA rejects Infi on safety"  
[X Link](https://x.com/DwightS2025/status/2022322957821882390) [@DwightS2025](/creator/x/DwightS2025) 2026-02-13T14:52Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing